title: Does alpha-interferon in conjunction with radiotherapy increase the risk of complications in the central nervous system?
authors.forename: H
authors.initials: H
authors.lastname: Hagberg
authors.forename: E
authors.initials: E
authors.lastname: Blomkvist
authors.forename: U
authors.initials: U
authors.lastname: Ponten
authors.forename: L
authors.initials: L
authors.lastname: Persson
authors.forename: C
authors.initials: C
authors.lastname: Muhr
authors.forename: B
authors.initials: B
authors.lastname: Eriksson
authors.forename: K
authors.initials: K
authors.lastname: Oberg
authors.forename: Y
authors.initials: Y
authors.lastname: Olsson
authors.forename: A
authors.initials: A
authors.lastname: Lilja
mesh_terms: D000328:Adult; D001927:Brain Diseases / Q000209:etiology*; D003131:Combined Modality Therapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011832:Radiation Injuries / Q000209:etiology*
chemical_list: D007370:Interferon Type I